Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease
Authors
Keywords
-
Journal
Expert Opinion on Drug Discovery
Volume 10, Issue 1, Pages 17-36
Publisher
Informa Healthcare
Online
2014-12-09
DOI
10.1517/17460441.2014.966680
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569
- (2014) Thomas F. Gamage et al. BEHAVIOURAL PHARMACOLOGY
- Use of a Synthetic Cannabinoid in a Correctional Population for Posttraumatic Stress Disorder–Related Insomnia and Nightmares, Chronic Pain, Harm Reduction, and Other Indications
- (2014) Colin Cameron et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Relationships between serotonergic and cannabinoid system in depressive-like behavior: a PET study with [11C]-DASB
- (2014) Aurelijus Burokas et al. JOURNAL OF NEUROCHEMISTRY
- Cannabinoids Prevent the Effects of a Footshock Followed by Situational Reminders on Emotional Processing
- (2014) Nachshon Korem et al. NEUROPSYCHOPHARMACOLOGY
- Towards a personalized treatment in depression: endocannabinoids, inflammation and stress response
- (2014) Zuzanna E Zajkowska et al. PHARMACOGENOMICS
- Release of endogenous cannabinoids from ventral tegmental area dopamine neurons and the modulation of synaptic processes
- (2014) Huikun Wang et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Behavioral and electrophysiological effects of endocannabinoid and dopaminergic systems on salient stimuli
- (2014) Daniela Laricchiuta et al. Frontiers in Behavioral Neuroscience
- Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms
- (2014) Petra Amchova et al. Frontiers in Pharmacology
- Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study
- (2013) A Neumeister et al. MOLECULAR PSYCHIATRY
- The role of glucocorticoids, catecholamines and endocannabinoids in the development of traumatic memories and posttraumatic stress symptoms in survivors of critical illness
- (2013) Daniela Hauer et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Cannabinoids and glucocorticoids modulate emotional memory after stress
- (2013) Irit Akirav NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Cannabinoid-induced upregulation of serotonin 2A receptors in the hypothalamic paraventricular nucleus and anxiety-like behaviors in rats
- (2013) Jade M. Franklin et al. NEUROSCIENCE LETTERS
- Enhanced novelty-induced corticosterone spike and upregulated serotonin 5-HT1A and cannabinoid CB1 receptors in adolescent BTBR mice
- (2013) Georgianna G. Gould et al. PSYCHONEUROENDOCRINOLOGY
- Amygdala FAAH and anandamide: mediating protection and recovery from stress
- (2013) Ozge Gunduz-Cinar et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Mitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence
- (2012) Torsten Passie et al. Drug Testing and Analysis
- Allosteric Modulator ORG27569 Induces CB1 Cannabinoid Receptor High Affinity Agonist Binding State, Receptor Internalization, and GiProtein-independent ERK1/2 Kinase Activation
- (2012) Kwang H. Ahn et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Indole-2-carboxamides as Allosteric Modulators of the Cannabinoid CB1 Receptor
- (2012) Francesco Piscitelli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
- (2012) Mark J. Millan et al. NATURE REVIEWS DRUG DISCOVERY
- Cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala prevent the stress-induced enhancement of a negative learning experience
- (2012) Assaf Ramot et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Endocannabinoid Signaling and Synaptic Function
- (2012) Pablo E. Castillo et al. NEURON
- A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: Potential extinction enhancers
- (2012) Rafael Mariano de Bitencourt et al. NEUROPHARMACOLOGY
- Cannabinoid facilitation of fear extinction memory recall in humans
- (2012) Christine A. Rabinak et al. NEUROPHARMACOLOGY
- The CB2-preferring agonist JWH015 also potently and efficaciously activates CB1 in autaptic hippocampal neurons
- (2012) N. Murataeva et al. PHARMACOLOGICAL RESEARCH
- Endocannabinoid system and mood disorders: Priming a target for new therapies
- (2012) Vincenzo Micale et al. PHARMACOLOGY & THERAPEUTICS
- Lipoxin A4 is an allosteric endocannabinoid that strengthens anandamide-induced CB1 receptor activation
- (2012) R. G. Pertwee PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor
- (2012) F. A. Pamplona et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glucocorticoids interact with the hippocampal endocannabinoid system in impairing retrieval of contextual fear memory
- (2012) P. Atsak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cannabinoid modulation of noradrenergic circuits: Implications for psychiatric disorders
- (2012) Ana Franky Carvalho et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Interactions between the cannabinoid and dopaminergic systems: Evidence from animal studies
- (2012) Marie-Anne El Khoury et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Recruitment of Prefrontal Cortical Endocannabinoid Signaling by Glucocorticoids Contributes to Termination of the Stress Response
- (2011) M. N. Hill et al. JOURNAL OF NEUROSCIENCE
- CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity
- (2011) Emmanuel S Onaivi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Modulation of the serotonin system by endocannabinoid signaling
- (2011) Samir Haj-Dahmane et al. NEUROPHARMACOLOGY
- Cannabinoids and monoamine neurotransmission with focus on monoamine oxidase
- (2011) Zdeněk Fišar PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Exploração farmacológica do sistema endocanabinoide: novas perspectivas para o tratamento de transtornos de ansiedade e depressão?
- (2011) Viviane M. Saito et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- How the Neurocircuitry and Genetics of Fear Inhibition May Inform Our Understanding of PTSD
- (2010) Tanja Jovanovic et al. AMERICAN JOURNAL OF PSYCHIATRY
- Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models
- (2010) Daniel T Malone et al. BRITISH JOURNAL OF PHARMACOLOGY
- The endocannabinoid system and psychiatric disorders
- (2010) Daniela Parolaro et al. EXPERIMENTAL NEUROLOGY
- Prazosin Versus Quetiapine for Nighttime Posttraumatic Stress Disorder Symptoms in Veterans
- (2010) Melanie G. Byers et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Functional Interactions between Stress and the Endocannabinoid System: From Synaptic Signaling to Behavioral Output
- (2010) M. N. Hill et al. JOURNAL OF NEUROSCIENCE
- Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight
- (2010) Vincenzo Di Marzo NATURE NEUROSCIENCE
- Inhibition of monoamine oxidase activity by cannabinoids
- (2010) Zdeněk Fišar NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Endogenous cannabinoid signaling is essential for stress adaptation
- (2010) M. N. Hill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ultrastructural Localization of Neuronal Brain CB2 Cannabinoid Receptors
- (2009) A. Brusco et al. Annals of the New York Academy of Sciences
- Noradrenergic modulation of extinction learning and exposure therapy
- (2009) Devin Mueller et al. BEHAVIOURAL BRAIN RESEARCH
- Physiological roles of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand
- (2009) Takayuki Sugiura BIOFACTORS
- Characterization of cannabinoid-1 receptors in the locus coeruleus: Relationship with mu-opioid receptors
- (2009) Jillian L. Scavone et al. BRAIN RESEARCH
- 5-HT1Areceptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats
- (2009) Leonardo B.M. Resstel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Positive allosteric modulation of the human cannabinoid (CB1) receptor by RTI-371, a selective inhibitor of the dopamine transporter
- (2009) Hernán A. Navarro et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effect of the CB1 receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices
- (2009) Aitziber Mendiguren et al. BRITISH JOURNAL OF PHARMACOLOGY
- Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis
- (2009) Dagmar Koethe et al. BRITISH JOURNAL OF PSYCHIATRY
- The Use of a Synthetic Cannabinoid in the Management of Treatment-Resistant Nightmares in Posttraumatic Stress Disorder (PTSD)
- (2009) George A. Fraser CNS Neuroscience & Therapeutics
- From endocannabinoid profiling to ‘endocannabinoid therapeutics’
- (2009) Alessia Ligresti et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Monoaminergic neurotransmission contributes to cannabinoid-induced activation of the hypothalamic-pituitary-adrenal axis
- (2009) Ryan J. McLaughlin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Synthetic Δ-9-Tetrahydrocannabinol (Dronabinol) Can Improve the Symptoms of Schizophrenia
- (2009) Glenn Schwarcz et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Alteration of Theta Timescale Dynamics of Hippocampal Place Cells by a Cannabinoid Is Associated with Memory Impairment
- (2009) D. Robbe et al. JOURNAL OF NEUROSCIENCE
- Endocannabinoids Suppress Excitatory Synaptic Transmission to Dorsal Raphe Serotonin Neurons through the Activation of Presynaptic CB1 Receptors
- (2009) S. Haj-Dahmane et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The locus coeruleus and noradrenergic modulation of cognition
- (2009) Susan J. Sara NATURE REVIEWS NEUROSCIENCE
- Delayed Increase of Brain Noradrenaline After Acute Footshock Stress in Rats
- (2009) Toshikazu Shinba et al. NEUROCHEMICAL RESEARCH
- Repeated Homotypic Stress Elevates 2-Arachidonoylglycerol Levels and Enhances Short-Term Endocannabinoid Signaling at Inhibitory Synapses in Basolateral Amygdala
- (2009) Sachin Patel et al. NEUROPSYCHOPHARMACOLOGY
- Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory
- (2009) P. Campolongo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Endocannabinoids: The silent partner of glucocorticoids in the synapse
- (2009) M. N. Hill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids
- (2009) Matthew N. Hill et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The future of endocannabinoid-oriented clinical research after CB1 antagonists
- (2009) Bernard Le Foll et al. PSYCHOPHARMACOLOGY
- Prazosin for treatment of nightmares related to posttraumatic stress disorder
- (2008) Heather R. Taylor et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia
- (2008) Stephen M. Eggan et al. ARCHIVES OF GENERAL PSYCHIATRY
- Convergent regulation of locus coeruleus activity as an adaptive response to stress
- (2008) Rita J. Valentino et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators
- (2008) Bruce S. McEwen EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia
- (2008) Kirsten R Müller-Vahl et al. Expert Review of Neurotherapeutics
- Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1knockout mice
- (2008) Ester Aso et al. JOURNAL OF NEUROCHEMISTRY
- Noradrenergic Signaling in Infralimbic Cortex Increases Cell Excitability and Strengthens Memory for Fear Extinction
- (2008) D. Mueller et al. JOURNAL OF NEUROSCIENCE
- Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
- (2008) Jonathan Z Long et al. Nature Chemical Biology
- Regulation of endocannabinoid signaling by stress: Implications for stress-related affective disorders
- (2008) Boris B. Gorzalka et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Cannabidiol potentiates pharmacological effects of Δ9-tetrahydrocannabinol via CB1 receptor-dependent mechanism
- (2007) Kazuhide Hayakawa et al. BRAIN RESEARCH
- PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats
- (2007) J G Horswill et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus
- (2007) Matthew N. Hill et al. HIPPOCAMPUS
- Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness
- (2006) Moussa B H Youdim et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now